Erika Sullivan, MD, MS, MS
Assistant Professor of Clinical Medicine, Medical Operations Officer for DFPM, PCMH Liason for DFPM, Co-Medical Director of the University Transgender Health Program
University of Utah Department of Family and Preventive Medicine
University of Utah, Department of Family and Preventive Medicine
Nothing to disclose
There are multiple societies and organizations that have issued either standards of care or clinical guidelines for transgender hormone treatment. We sought to evaluate our group's adherence to these recommendations. We hypothesized that we provide competent hormone therapy to our transgender patients, but that there is likely also room for standardization and quality improvement tools to drive us towards "Perfect Care."
Methods : 1. Created a table that cross walks all available guidelines and standards of care to define a consensus statement regarding monitoring hormone therapy safety and adherence
2. We defined the essential elements of safety and adherence to these guidelines which described "Perfect Care"
3. We performed a chart review to assess our baseline performance and adherence to the definition of perfect care
4. We proposed interventions, in the form of mini-process improvement cycles, to improve the care we provide to the TG/GNC community that we serve
Results : No results at the time of the writing of this proposal. We are in the process of collecting the data for analytics. We will present our definitions for Perfect Care and the baseline performance of our group vis-à-vis these guidelines if selected for a workshop at the conference.
Conclusions : Our research attempts to define quality metrics that can provide the basis for data-driven quality improvement work in transgender medicine. We hope to show that our group is practicing high quality and data-driven care, but that with all programs, there is room for improvement. We recognize that transgender medicine is well poised for development of quality improvement studies, inquiry, research and scholarship.